My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Executed MOU Between Greater Columbia to Establish Opioid Abatement Council
>
Meetings
>
2023
>
06. June
>
2023-06-20 10:00 AM - Commissioners' Agenda
>
Executed MOU Between Greater Columbia to Establish Opioid Abatement Council
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/12/2023 12:09:38 PM
Creation date
9/12/2023 12:09:27 PM
Metadata
Fields
Template:
Meeting
Date
6/20/2023
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Fully Executed Version
Supplemental fields
Item
Request to Approve a Memorandum of Understanding between the Greater Columbia Region Municipalities to Establish and Opioid Abatement Council
Order
13
Placement
Consent Agenda
Row ID
104780
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
16
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
F OVER-P BING AND APP <br />DISPENSING oF oPtoDs <br />Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing <br />of opioids through evidence-based, evidence-informed, or promising programs or strategies that <br />may include, but are not limited to, the following: <br />t. Training for health care providers regarding safe and responsible opioid prescribing, <br />dosing, and tapering patients off opioids. <br />2. Academic counter-detailing to educate prescribers on appropriated opioid <br />prescribing. <br />3. continuing Medical Education (cME) on appropriate prescribing of opioids.4. Support for non-opioid pain treatment alternatives, including training providers to <br />offer or refer to multi-modal, evidence-informed treatment of pain. <br />5. Support enhancements or improvements to Prescription Drug Monitoring programs <br />(PSMPs), including but not limited to improvements that: <br />A. lncrease the number of prescribers using pDMps; <br />B. lmprove point-of-care decision-making by increasing the quantity, quality, or <br />format of data available to prescribers using PDMPs or by improving the <br />interface that prescribers use to access pDMp data, or both; or <br />C. Enable states to use PDMP data in support of surveillance or intervention <br />strategies, including MAT referrals and follow-up for individuals identified <br />within PDMP data as likely to experience OUD. <br />6. Development and implementation of a national PDMP - Fund development of a <br />multistate/national PDMP that permits information sharing while providing <br />appropriate safeguards on sharing of private health information, including but not <br />limited to: <br />a. lntegration of PDMP data with electronic health records, overdose episodes, <br />and decision support tools for health care providers relating to OUD.b. Ensuring PDMPs incorporate available overdose/naloxone deployment data, <br />including the United States Department of Transportation's Emergency <br />Medical Technician overdose database. <br />7. lncrease electronic prescribing to prevent diversion or forgery. <br />8. Educate Dispensers on appropriate opioid dispensing. <br />G. PREVENT MISUSE OF OPIOI DS <br />Support efforts to discourage or prevent misuse of opioids through evidence-based, <br />evidence-informed, or promising programs or strategies that may include, but are not limited <br />to, the following: <br />1. Corrective advertising or affirmative public education campaigns based on evidence.2. Public education relating to drug disposal.
The URL can be used to link to this page
Your browser does not support the video tag.